New Pharmaceuticals market report from Global Markets Direct: "Gentium S.p.A. - Product Pipeline Review - 2013"
Boston, MA -- (SBWIRE) -- 02/14/2014 -- Global Market Direct's pharmaceuticals report, "Gentium S.p.A. - Product Pipeline Review - 2013" provides data on the Gentium S.p.A.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Gentium S.p.A.'s corporate website, SEC filings, investor presentations and featured press releases, both from Gentium S.p.A. and industry-specific third party sources, put together by Global Markets Direct's team.
- Gentium S.p.A. - Brief Gentium S.p.A. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Gentium S.p.A. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Gentium S.p.A. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Gentium S.p.A.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
View Full Report Details and Table of Contents
Reasons to Get This Report
- Evaluate Gentium S.p.A.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Gentium S.p.A. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Gentium S.p.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Gentium S.p.A..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Gentium S.p.A. and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Axxam SpA - Product Pipeline Review - 2013
- AEterna Zentaris Inc. - Product Pipeline Review - 2013
- Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2013
- Novo Nordisk A/S - Product Pipeline Review - 2013
- Metastatic Pancreatic Cancer - Pipeline Review, H2 2013
- Evotec AG - Product Pipeline Review - 2013
- Mild Cognitive Impairment - Pipeline Review, H1 2013
- Respiratory Distress Syndrome - Pipeline Review, H1 2013
- Cancer Pain - Pipeline Review, H2 2013
- Actelion Ltd - Product Pipeline Review - 2013